A5023447823- Reconstructive Surgery and Microvascular Techniques
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Surgical Treatments
- Cardiomyopathy and Myosin Studies
- Breast Implant and Reconstruction
- Anorectal Disease Treatments and Outcomes
- Congenital Heart Disease Studies
- Body Contouring and Surgery
- Breast Cancer Treatment Studies
- Orthopaedic implants and arthroplasty
- Congenital gastrointestinal and neural anomalies
- Cardiovascular Disease and Adiposity
- Intestinal Malrotation and Obstruction Disorders
- Head and Neck Cancer Studies
- Oral Health Pathology and Treatment
- Reconstructive Facial Surgery Techniques
- Minimally Invasive Surgical Techniques
- Hip and Femur Fractures
- Gastrointestinal disorders and treatments
- Hidradenitis Suppurativa and Treatments
- Colorectal Cancer Treatments and Studies
- Tracheal and airway disorders
- Colorectal and Anal Carcinomas
- Cancer Immunotherapy and Biomarkers
- Autoimmune and Inflammatory Disorders
Changchun Normal University
2025
Shengli Oilfield Central Hospital
2024
Health Sciences North
2018-2022
Bristol-Myers Squibb (United States)
2021
Children's National
2020
NOSM University
2017-2018
Piedmont Atlanta Hospital
2009-2012
Emory University
2000-2002
Emory Clinic
2000
Organ-sparing therapy for early-stage I/IIA rectal cancer is intended to avoid functional disturbances or a permanent ostomy associated with total mesorectal excision (TME). The objective of this phase II trial was determine the outcomes and organ-sparing rate patients treated neoadjuvant chemotherapy followed by transanal surgery (TES).This included clinical T1-T3abN0 low- mid-rectal adenocarcinoma eligible endoscopic resection who were 3 months (modified folinic...
Abstract Introduction Transanal total mesorectal excision (taTME) is a novel approach to surgery for rectal cancer. The technique has gained significant popularity in the surgical community due promising ability overcome technical difficulties related access of distal pelvis. Recently, Norwegian surgeons issued local moratorium potential issues with safety procedure. Early adopters taTME Canada have recognized need create guidelines its adoption and supervision. objective statement provide...
Introduction: In the phase 2 MAVERICK-HCM study in patients (pts) with non-obstructive hypertrophic cardiomyopathy (nHCM), mavacamten, a cardiac myosin inhibitor, was well tolerated and associated significant reduction biomarkers of myocardial wall stress injury over 16 weeks (wks). Long-term efficacy safety mavacamten are being evaluated MAVA-LTE. Methods: Pts who completed were eligible to enroll MAVERICK-LTE cohort received continued on same dose; pts placebo randomized (1:1) 1 target...
Pyoderma gangrenosum is a progressively necrotizing and ulcerative skin disease that mimics severe bacterial infection. However, the cause not infectious in nature lesions are refractory to local wound care antibiotic therapy. The etiology of pyoderma remains unknown, although pathogenic mechanisms may involve immunologically mediated cutaneous damage. authors report 67-year-old woman whom necrotic ulcer developed at chest tube site. Treated with antibiotics, this lesion spread 15% her body...
Ma, Grace M.D.; Richardson, Heather Pacella, Salvatore J. M.D., M.B.A.; Codner, Mark A. M.D. Author Information
Intertrochanteric femur fractures are prevalent among the elderly, leading to substantial morbidity. Proximal femoral nail anti-rotation (PFNA) is commonly used for internal fixation, but excessive lateral migration of PFNA blade poses a significant complication. Understanding risk factors this complication crucial optimizing patient care.
<h3>Background</h3> Interactions between the immune system and tumor are now recognized as key determinants of clinical outcome in colorectal cancer (CRC). Immune landscapes have been extensively studied within resected primary tumors markers, such T cells, found to be associated with CRC patients' survival. Little is known about profile cells peripheral blood. We hypothesize that functional status characterized by their response tumor-associated antigens (TAAs), can monitored blood patients...